"Jointly organised by AusBiotech and Beacon Events, Australia Biotech Invest 2013 will be Australia’s largest biotech investment event to date, attracting over 300+ senior life science professionals from Australia and across the globe.
To be held on 28-29 October in Melbourne, one of the great life science hubs in the world, Australia Biotech Invest 2013 features a mix of expert keynotes, investor panels and biotech company presentations. As such, the conference merges valuable market intelligence with actual investment opportunities.
Come and meet with the leading investors and big pharma representatives that are funding biotech today and discuss investment, partnership or business opportunities with the line-up of cutting-edge biotech companies presenting at the event.
Six reasons why attending Australia Biotech Invest 2013 will be worth your while:
-Hear from an international line-up of industry experts and life science investors about the latest trends and opportunities in global biotech investment, capital raising and partnering.
-Gain insight into successful business models, IP strategies and R&D tax incentive opportunities.
-Learn how to set up partnerships in Asia and access investment out of China
-View a range of 30+ listed and private biotech companies present their pipelines
-Browse the 40+ booths at the on-site exhibition and identify new business opportunities
-Enjoy high-value networking and dealmaking opportunities with international investors, big pharma, CMOs/CROs, brokers and industry analysts. Plus, you can set up 1-on-1 meetings via our advanced online business partnering system"
http://ausbiotechinvest.com/conference-day-two/
CGP Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
